ArticleAntimicrobial agents and chemotherapy2018
Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.
Open access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 45 citations in OpenAlex.
- Disulfiram and Its Derivatives: An Immortal Phoenix of Drug Repurposing.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges.Journal of the American Chemical Society · 2025Review
- Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract.Frontiers in cellular and infection microbiology · 2025Review
- The Triple Combination of Meropenem, Avibactam, and a Metallo-β-Lactamase Inhibitor Optimizes Antibacterial Coverage Against Different β-Lactamase Producers.Engineering (Beijing, China) · 2024Article
- [Cu(NNInternational journal of molecular sciences · 2024Article
- Molecular mechanisms of tigecycline-resistance amongFrontiers in cellular and infection microbiology · 2024Review
- Oral administration of a new copper (I) complex with coumarin as ligand: modulation of the immune response and the composition of the intestinal microbiota inFrontiers in chemistry · 2024Article
- Article
- The Impact of Copper Ions on the Activity of Antibiotic Drugs.Molecules (Basel, Switzerland) · 2023Review
- A Ternary Copper (II) Complex with 4-Fluorophenoxyacetic Acid Hydrazide in Combination with Antibiotics Exhibits Positive Synergistic Effect againstAntibiotics (Basel, Switzerland) · 2022Article
- Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.Microbiology spectrum · 2022Article
- Metallo-β-lactamases and a tug-of-war for the available zinc at the host-pathogen interface.Current opinion in chemical biology · 2022Review
- Copper Homeostatic Mechanisms and Their Role in the Virulence of Escherichia coli and Salmonella enterica.EcoSal Plus · 2021Review
- Membrane Transporters Involved in the Antimicrobial Activities of Pyrithione inMolecules (Basel, Switzerland) · 2021Article
- Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.Chemical reviews · 2021Review
- A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.ACS infectious diseases · 2020Article
- Effects of a specific nutrient combination on ESBL resistance.Saudi journal of biological sciences · 2019Article
- Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit.Inorganic chemistry · 2019Review
- Article
- High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus.Metallomics : integrated biometal science · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 4 institutions in 4 countries.
Karrera Y Djoko *School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-9814-6515
Maud E S Achard *School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Minh-Duy PhanSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-3426-1044
Alvin W LoSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Manfredi MiraulaSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Sasiprapa PrombhulSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Steven J HancockSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-7203-2640
Kate M PetersSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Hanna E SidjabatAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-5625-1317
Patrick N HarrisAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Nataša MitićDepartment of Chemistry, Maynooth University, Maynooth, County Kildare, Ireland.
Timothy R WalshSchool of Medicine, Cardiff University, Cardiff, United Kingdom.
Gregory J AndersonSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
William M ShaferDepartment of Microbiology and Immunology and Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA.
David L PatersonAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Gerhard SchenkSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-8619-0631
Alastair G McEwanSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Mark A SchembriSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia m.schembri@uq.edu.au.ORCID 0000-0003-4863-9260
The University of Queensland · AUNational University of Ireland, Maynooth · IECardiff University · GBEmory University · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenem-resistant
Indexed as
Adjuvants, PharmaceuticAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-LactamsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsCoordination ComplexesCopperErtapenemEscherichia coliHumansIonsMeropenemMicrobial Sensitivity TestsUrinary Tract InfectionsAdjuvants, PharmaceuticAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-Lactamasesbeta-LactamscarbapenemaseCarbapenemsCoordination ComplexesCopperErtapenemIonsMeropenemantibiotic resistancecarbapenem-resistant Enterobacteriaceaecoppermetallo-β-lactamaseurinary tract infection
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.